GSK Raises Guidance After Sales, Earnings Growth
PositiveFinancial Markets

GSK has raised its sales growth guidance for 2025, now projecting an increase of 6% to 7% when excluding currency fluctuations, a significant improvement from the previous estimate of 3% to 5%. This positive adjustment reflects the company's strong performance and confidence in its future, which is crucial for investors and stakeholders as it indicates a robust pipeline and market demand for its products.
— Curated by the World Pulse Now AI Editorial System








